|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$89,913.33 |
2.80% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$89,930.32 |
2.80% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$84,621.60 |
2.63% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$83,881.97 |
2.61% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$83,645.22 |
2.60% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$83,463.81 |
2.60% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$81,804.70 |
2.55% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$81,086.74 |
2.52% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$78,919.92 |
2.46% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$78,183.36 |
2.43% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$77,280.63 |
2.41% |
| Waters Corporation |
WAT |
941848103 |
184 |
$76,302.96 |
2.38% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$75,500.80 |
2.35% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$73,870.11 |
2.30% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$73,417.24 |
2.29% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$72,396.64 |
2.25% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$72,251.68 |
2.25% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$70,741.46 |
2.20% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$69,555.66 |
2.17% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$68,288.97 |
2.13% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$67,757.24 |
2.11% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$67,574.49 |
2.10% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$66,981.70 |
2.09% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$66,132.36 |
2.06% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$63,876.03 |
1.99% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$63,580.81 |
1.98% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$62,903.59 |
1.96% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$62,936.10 |
1.96% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$62,005.14 |
1.93% |
| Steris Plc |
STE |
G8473T100 |
265 |
$61,951.70 |
1.93% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$61,671.48 |
1.92% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$60,992.33 |
1.90% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$58,928.76 |
1.83% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$57,882.07 |
1.80% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$57,540.06 |
1.79% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$57,259.04 |
1.78% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$55,435.67 |
1.73% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$54,096.77 |
1.68% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$54,096.44 |
1.68% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$53,577.20 |
1.67% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$50,580.18 |
1.57% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$48,651.35 |
1.51% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$48,438.00 |
1.51% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$47,194.27 |
1.47% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$46,302.78 |
1.44% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$44,823.18 |
1.40% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$44,732.20 |
1.39% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$43,539.00 |
1.36% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$41,351.30 |
1.29% |
| US Dollar |
$USD |
|
13,899 |
$13,898.63 |
0.43% |
| Yuan Renminbi |
$CNY |
|
1,824 |
$271.11 |
0.01% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|